Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
NeoMET Study in Neoadjuvant Treatment of Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"
- Status
- COMPLETED
- Phase
- PHASE2
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Trial for Large ER-Negative Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of LB-100 With Docetaxel in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2